Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union.
Identifieur interne : 000467 ( PubMed/Corpus ); précédent : 000466; suivant : 000468Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union.
Auteurs : Jürgen Rehm ; Peter Anderson ; Jose Angel Arbesu Prieto ; Iain Armstrong ; Henri-Jean Aubin ; Michael Bachmann ; Nuria Bastida Bastus ; Carlos Brotons ; Robyn Burton ; Manuel Cardoso ; Joan Colom ; Daniel Duprez ; Gerrit Gmel ; Antoni Gual ; Ludwig Kraus ; Reinhold Kreutz ; Helena Liira ; Jakob Manthey ; Lars M Ller ; Ubomír Okruhlica ; Michael Roerecke ; Emanuele Scafato ; Bernd Schulte ; Lidia Segura-Garcia ; Kevin David Shield ; Cristina Sierra ; Konstantin Vyshinskiy ; Marcin Wojnar ; José ZarcoSource :
- BMC medicine [ 1741-7015 ] ; 2017.
Abstract
Hazardous and harmful alcohol use and high blood pressure are central risk factors related to premature non-communicable disease (NCD) mortality worldwide. A reduction in the prevalence of both risk factors has been suggested as a route to reach the global NCD targets. This study aims to highlight that screening and interventions for hypertension and hazardous and harmful alcohol use in primary healthcare can contribute substantially to achieving the NCD targets.
DOI: 10.1186/s12916-017-0934-1
PubMed: 28954635
Links to Exploration step
pubmed:28954635Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union.</title><author><name sortKey="Rehm, Jurgen" sort="Rehm, Jurgen" uniqKey="Rehm J" first="Jürgen" last="Rehm">Jürgen Rehm</name><affiliation><nlm:affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Anderson, Peter" sort="Anderson, Peter" uniqKey="Anderson P" first="Peter" last="Anderson">Peter Anderson</name><affiliation><nlm:affiliation>Substance Use, Policy and Practice, Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Prieto, Jose Angel Arbesu" sort="Prieto, Jose Angel Arbesu" uniqKey="Prieto J" first="Jose Angel Arbesu" last="Prieto">Jose Angel Arbesu Prieto</name><affiliation><nlm:affiliation>Primary Care Center La Eria, Oviedo, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Armstrong, Iain" sort="Armstrong, Iain" uniqKey="Armstrong I" first="Iain" last="Armstrong">Iain Armstrong</name><affiliation><nlm:affiliation>Health and Wellbeing Directorate, Public Health England, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Aubin, Henri Jean" sort="Aubin, Henri Jean" uniqKey="Aubin H" first="Henri-Jean" last="Aubin">Henri-Jean Aubin</name><affiliation><nlm:affiliation>CESP, University Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, APHP, Hôpitaux Universitaires Paris-Sud, Villejuif, France.</nlm:affiliation></affiliation></author><author><name sortKey="Bachmann, Michael" sort="Bachmann, Michael" uniqKey="Bachmann M" first="Michael" last="Bachmann">Michael Bachmann</name><affiliation><nlm:affiliation>Copentown Healthcare Consultants, Cape Town, South Africa.</nlm:affiliation></affiliation></author><author><name sortKey="Bastus, Nuria Bastida" sort="Bastus, Nuria Bastida" uniqKey="Bastus N" first="Nuria Bastida" last="Bastus">Nuria Bastida Bastus</name><affiliation><nlm:affiliation>Primary Health Center, Raval Nord, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Brotons, Carlos" sort="Brotons, Carlos" uniqKey="Brotons C" first="Carlos" last="Brotons">Carlos Brotons</name><affiliation><nlm:affiliation>Sardenya Primary Health Care Center, Biomedical Research Institute Sant Pau, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Burton, Robyn" sort="Burton, Robyn" uniqKey="Burton R" first="Robyn" last="Burton">Robyn Burton</name><affiliation><nlm:affiliation>Health and Wellbeing Directorate, Public Health England, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Cardoso, Manuel" sort="Cardoso, Manuel" uniqKey="Cardoso M" first="Manuel" last="Cardoso">Manuel Cardoso</name><affiliation><nlm:affiliation>General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD), Lisbon, Portugal.</nlm:affiliation></affiliation></author><author><name sortKey="Colom, Joan" sort="Colom, Joan" uniqKey="Colom J" first="Joan" last="Colom">Joan Colom</name><affiliation><nlm:affiliation>Program on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Duprez, Daniel" sort="Duprez, Daniel" uniqKey="Duprez D" first="Daniel" last="Duprez">Daniel Duprez</name><affiliation><nlm:affiliation>Cardiovascular Division, School of Medicine, University of Minnesota, Minneapolis, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gmel, Gerrit" sort="Gmel, Gerrit" uniqKey="Gmel G" first="Gerrit" last="Gmel">Gerrit Gmel</name><affiliation><nlm:affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Gual, Antoni" sort="Gual, Antoni" uniqKey="Gual A" first="Antoni" last="Gual">Antoni Gual</name><affiliation><nlm:affiliation>Addictions Unit, Psychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Kraus, Ludwig" sort="Kraus, Ludwig" uniqKey="Kraus L" first="Ludwig" last="Kraus">Ludwig Kraus</name><affiliation><nlm:affiliation>IFT Institut für Therapieforschung, Munich, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Kreutz, Reinhold" sort="Kreutz, Reinhold" uniqKey="Kreutz R" first="Reinhold" last="Kreutz">Reinhold Kreutz</name><affiliation><nlm:affiliation>Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Liira, Helena" sort="Liira, Helena" uniqKey="Liira H" first="Helena" last="Liira">Helena Liira</name><affiliation><nlm:affiliation>General Practice, School of Primary, Aboriginal and Rural Health Care, University of Western Australia, Perth, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Manthey, Jakob" sort="Manthey, Jakob" uniqKey="Manthey J" first="Jakob" last="Manthey">Jakob Manthey</name><affiliation><nlm:affiliation>Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany. jakob.manthey@tu-dresden.de.</nlm:affiliation></affiliation></author><author><name sortKey="M Ller, Lars" sort="M Ller, Lars" uniqKey="M Ller L" first="Lars" last="M Ller">Lars M Ller</name><affiliation><nlm:affiliation>Division of Noncommunicable Diseases through the Life Course, WHO Regional Office for Europe, Copenhagen, Denmark.</nlm:affiliation></affiliation></author><author><name sortKey="Okruhlica, Ubomir" sort="Okruhlica, Ubomir" uniqKey="Okruhlica " first=" Ubomír" last="Okruhlica"> Ubomír Okruhlica</name><affiliation><nlm:affiliation>Centrum pre Liecbu Drogovych Zavislosti, Bratislava, Slovakia.</nlm:affiliation></affiliation></author><author><name sortKey="Roerecke, Michael" sort="Roerecke, Michael" uniqKey="Roerecke M" first="Michael" last="Roerecke">Michael Roerecke</name><affiliation><nlm:affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Scafato, Emanuele" sort="Scafato, Emanuele" uniqKey="Scafato E" first="Emanuele" last="Scafato">Emanuele Scafato</name><affiliation><nlm:affiliation>National Observatory on Alcohol, National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Schulte, Bernd" sort="Schulte, Bernd" uniqKey="Schulte B" first="Bernd" last="Schulte">Bernd Schulte</name><affiliation><nlm:affiliation>Centre for Interdisciplinary Addiction Research, Hamburg University, Universitätsklinik Hamburg-Eppendorf, Hamburg, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Segura Garcia, Lidia" sort="Segura Garcia, Lidia" uniqKey="Segura Garcia L" first="Lidia" last="Segura-Garcia">Lidia Segura-Garcia</name><affiliation><nlm:affiliation>Program on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Shield, Kevin David" sort="Shield, Kevin David" uniqKey="Shield K" first="Kevin David" last="Shield">Kevin David Shield</name><affiliation><nlm:affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Sierra, Cristina" sort="Sierra, Cristina" uniqKey="Sierra C" first="Cristina" last="Sierra">Cristina Sierra</name><affiliation><nlm:affiliation>Hypertension and Vascular Risk Unit, Internal Medicine Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Vyshinskiy, Konstantin" sort="Vyshinskiy, Konstantin" uniqKey="Vyshinskiy K" first="Konstantin" last="Vyshinskiy">Konstantin Vyshinskiy</name><affiliation><nlm:affiliation>Research Institute on Addictions, Federal Medical Research Centre for Psychiatry and Narcology n.a. V. Serbsky, Moscow, Russia.</nlm:affiliation></affiliation></author><author><name sortKey="Wojnar, Marcin" sort="Wojnar, Marcin" uniqKey="Wojnar M" first="Marcin" last="Wojnar">Marcin Wojnar</name><affiliation><nlm:affiliation>Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland.</nlm:affiliation></affiliation></author><author><name sortKey="Zarco, Jose" sort="Zarco, Jose" uniqKey="Zarco J" first="José" last="Zarco">José Zarco</name><affiliation><nlm:affiliation>Drugs Intervention Group, semFYC, Ibiza Primary Health Care Center, Madrid, Spain.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28954635</idno><idno type="pmid">28954635</idno><idno type="doi">10.1186/s12916-017-0934-1</idno><idno type="wicri:Area/PubMed/Corpus">000467</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000467</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union.</title><author><name sortKey="Rehm, Jurgen" sort="Rehm, Jurgen" uniqKey="Rehm J" first="Jürgen" last="Rehm">Jürgen Rehm</name><affiliation><nlm:affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Anderson, Peter" sort="Anderson, Peter" uniqKey="Anderson P" first="Peter" last="Anderson">Peter Anderson</name><affiliation><nlm:affiliation>Substance Use, Policy and Practice, Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Prieto, Jose Angel Arbesu" sort="Prieto, Jose Angel Arbesu" uniqKey="Prieto J" first="Jose Angel Arbesu" last="Prieto">Jose Angel Arbesu Prieto</name><affiliation><nlm:affiliation>Primary Care Center La Eria, Oviedo, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Armstrong, Iain" sort="Armstrong, Iain" uniqKey="Armstrong I" first="Iain" last="Armstrong">Iain Armstrong</name><affiliation><nlm:affiliation>Health and Wellbeing Directorate, Public Health England, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Aubin, Henri Jean" sort="Aubin, Henri Jean" uniqKey="Aubin H" first="Henri-Jean" last="Aubin">Henri-Jean Aubin</name><affiliation><nlm:affiliation>CESP, University Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, APHP, Hôpitaux Universitaires Paris-Sud, Villejuif, France.</nlm:affiliation></affiliation></author><author><name sortKey="Bachmann, Michael" sort="Bachmann, Michael" uniqKey="Bachmann M" first="Michael" last="Bachmann">Michael Bachmann</name><affiliation><nlm:affiliation>Copentown Healthcare Consultants, Cape Town, South Africa.</nlm:affiliation></affiliation></author><author><name sortKey="Bastus, Nuria Bastida" sort="Bastus, Nuria Bastida" uniqKey="Bastus N" first="Nuria Bastida" last="Bastus">Nuria Bastida Bastus</name><affiliation><nlm:affiliation>Primary Health Center, Raval Nord, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Brotons, Carlos" sort="Brotons, Carlos" uniqKey="Brotons C" first="Carlos" last="Brotons">Carlos Brotons</name><affiliation><nlm:affiliation>Sardenya Primary Health Care Center, Biomedical Research Institute Sant Pau, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Burton, Robyn" sort="Burton, Robyn" uniqKey="Burton R" first="Robyn" last="Burton">Robyn Burton</name><affiliation><nlm:affiliation>Health and Wellbeing Directorate, Public Health England, London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Cardoso, Manuel" sort="Cardoso, Manuel" uniqKey="Cardoso M" first="Manuel" last="Cardoso">Manuel Cardoso</name><affiliation><nlm:affiliation>General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD), Lisbon, Portugal.</nlm:affiliation></affiliation></author><author><name sortKey="Colom, Joan" sort="Colom, Joan" uniqKey="Colom J" first="Joan" last="Colom">Joan Colom</name><affiliation><nlm:affiliation>Program on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Duprez, Daniel" sort="Duprez, Daniel" uniqKey="Duprez D" first="Daniel" last="Duprez">Daniel Duprez</name><affiliation><nlm:affiliation>Cardiovascular Division, School of Medicine, University of Minnesota, Minneapolis, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gmel, Gerrit" sort="Gmel, Gerrit" uniqKey="Gmel G" first="Gerrit" last="Gmel">Gerrit Gmel</name><affiliation><nlm:affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Gual, Antoni" sort="Gual, Antoni" uniqKey="Gual A" first="Antoni" last="Gual">Antoni Gual</name><affiliation><nlm:affiliation>Addictions Unit, Psychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Kraus, Ludwig" sort="Kraus, Ludwig" uniqKey="Kraus L" first="Ludwig" last="Kraus">Ludwig Kraus</name><affiliation><nlm:affiliation>IFT Institut für Therapieforschung, Munich, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Kreutz, Reinhold" sort="Kreutz, Reinhold" uniqKey="Kreutz R" first="Reinhold" last="Kreutz">Reinhold Kreutz</name><affiliation><nlm:affiliation>Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Liira, Helena" sort="Liira, Helena" uniqKey="Liira H" first="Helena" last="Liira">Helena Liira</name><affiliation><nlm:affiliation>General Practice, School of Primary, Aboriginal and Rural Health Care, University of Western Australia, Perth, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Manthey, Jakob" sort="Manthey, Jakob" uniqKey="Manthey J" first="Jakob" last="Manthey">Jakob Manthey</name><affiliation><nlm:affiliation>Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany. jakob.manthey@tu-dresden.de.</nlm:affiliation></affiliation></author><author><name sortKey="M Ller, Lars" sort="M Ller, Lars" uniqKey="M Ller L" first="Lars" last="M Ller">Lars M Ller</name><affiliation><nlm:affiliation>Division of Noncommunicable Diseases through the Life Course, WHO Regional Office for Europe, Copenhagen, Denmark.</nlm:affiliation></affiliation></author><author><name sortKey="Okruhlica, Ubomir" sort="Okruhlica, Ubomir" uniqKey="Okruhlica " first=" Ubomír" last="Okruhlica"> Ubomír Okruhlica</name><affiliation><nlm:affiliation>Centrum pre Liecbu Drogovych Zavislosti, Bratislava, Slovakia.</nlm:affiliation></affiliation></author><author><name sortKey="Roerecke, Michael" sort="Roerecke, Michael" uniqKey="Roerecke M" first="Michael" last="Roerecke">Michael Roerecke</name><affiliation><nlm:affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Scafato, Emanuele" sort="Scafato, Emanuele" uniqKey="Scafato E" first="Emanuele" last="Scafato">Emanuele Scafato</name><affiliation><nlm:affiliation>National Observatory on Alcohol, National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Schulte, Bernd" sort="Schulte, Bernd" uniqKey="Schulte B" first="Bernd" last="Schulte">Bernd Schulte</name><affiliation><nlm:affiliation>Centre for Interdisciplinary Addiction Research, Hamburg University, Universitätsklinik Hamburg-Eppendorf, Hamburg, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Segura Garcia, Lidia" sort="Segura Garcia, Lidia" uniqKey="Segura Garcia L" first="Lidia" last="Segura-Garcia">Lidia Segura-Garcia</name><affiliation><nlm:affiliation>Program on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Shield, Kevin David" sort="Shield, Kevin David" uniqKey="Shield K" first="Kevin David" last="Shield">Kevin David Shield</name><affiliation><nlm:affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Sierra, Cristina" sort="Sierra, Cristina" uniqKey="Sierra C" first="Cristina" last="Sierra">Cristina Sierra</name><affiliation><nlm:affiliation>Hypertension and Vascular Risk Unit, Internal Medicine Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Vyshinskiy, Konstantin" sort="Vyshinskiy, Konstantin" uniqKey="Vyshinskiy K" first="Konstantin" last="Vyshinskiy">Konstantin Vyshinskiy</name><affiliation><nlm:affiliation>Research Institute on Addictions, Federal Medical Research Centre for Psychiatry and Narcology n.a. V. Serbsky, Moscow, Russia.</nlm:affiliation></affiliation></author><author><name sortKey="Wojnar, Marcin" sort="Wojnar, Marcin" uniqKey="Wojnar M" first="Marcin" last="Wojnar">Marcin Wojnar</name><affiliation><nlm:affiliation>Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland.</nlm:affiliation></affiliation></author><author><name sortKey="Zarco, Jose" sort="Zarco, Jose" uniqKey="Zarco J" first="José" last="Zarco">José Zarco</name><affiliation><nlm:affiliation>Drugs Intervention Group, semFYC, Ibiza Primary Health Care Center, Madrid, Spain.</nlm:affiliation></affiliation></author></analytic><series><title level="j">BMC medicine</title><idno type="eISSN">1741-7015</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Hazardous and harmful alcohol use and high blood pressure are central risk factors related to premature non-communicable disease (NCD) mortality worldwide. A reduction in the prevalence of both risk factors has been suggested as a route to reach the global NCD targets. This study aims to highlight that screening and interventions for hypertension and hazardous and harmful alcohol use in primary healthcare can contribute substantially to achieving the NCD targets.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28954635</PMID><DateCreated><Year>2017</Year><Month>09</Month><Day>28</Day></DateCreated><DateRevised><Year>2017</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union.</ArticleTitle><Pagination><MedlinePgn>173</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-017-0934-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hazardous and harmful alcohol use and high blood pressure are central risk factors related to premature non-communicable disease (NCD) mortality worldwide. A reduction in the prevalence of both risk factors has been suggested as a route to reach the global NCD targets. This study aims to highlight that screening and interventions for hypertension and hazardous and harmful alcohol use in primary healthcare can contribute substantially to achieving the NCD targets.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A consensus conference based on systematic reviews, meta-analyses, clinical guidelines, experimental studies, and statistical modelling which had been presented and discussed in five preparatory meetings, was undertaken. Specifically, we modelled changes in blood pressure distributions and potential lives saved for the five largest European countries if screening and appropriate intervention rates in primary healthcare settings were increased. Recommendations to handle alcohol-induced hypertension in primary healthcare settings were derived at the conference, and their degree of evidence was graded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Screening and appropriate interventions for hazardous alcohol use and use disorders could lower blood pressure levels, but there is a lack in implementing these measures in European primary healthcare. Recommendations included (1) an increase in screening for hypertension (evidence grade: high), (2) an increase in screening and brief advice on hazardous and harmful drinking for people with newly detected hypertension by physicians, nurses, and other healthcare professionals (evidence grade: high), (3) the conduct of clinical management of less severe alcohol use disorders for incident people with hypertension in primary healthcare (evidence grade: moderate), and (4) screening for alcohol use in hypertension that is not well controlled (evidence grade: moderate). The first three measures were estimated to result in a decreased hypertension prevalence and hundreds of saved lives annually in the examined countries.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The implementation of the outlined recommendations could contribute to reducing the burden associated with hypertension and hazardous and harmful alcohol use and thus to achievement of the NCD targets. Implementation should be conducted in controlled settings with evaluation, including, but not limited to, economic evaluation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rehm</LastName><ForeName>Jürgen</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-5665-0385</Identifier><AffiliationInfo><Affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Addiction Policy, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Faculty of Medicine, Medical Sciences Building, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Substance Use, Policy and Practice, Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alcohol and Health, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto</LastName><ForeName>Jose Angel Arbesu</ForeName><Initials>JAA</Initials><AffiliationInfo><Affiliation>Primary Care Center La Eria, Oviedo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Primary Care Spanish Society SEMERGEN, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Iain</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Health and Wellbeing Directorate, Public Health England, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aubin</LastName><ForeName>Henri-Jean</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>CESP, University Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, APHP, Hôpitaux Universitaires Paris-Sud, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachmann</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Copentown Healthcare Consultants, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastus</LastName><ForeName>Nuria Bastida</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>Primary Health Center, Raval Nord, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brotons</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sardenya Primary Health Care Center, Biomedical Research Institute Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burton</LastName><ForeName>Robyn</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Health and Wellbeing Directorate, Public Health England, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD), Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colom</LastName><ForeName>Joan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Program on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duprez</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, School of Medicine, University of Minnesota, Minneapolis, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gmel</LastName><ForeName>Gerrit</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Implant Systems Group, National ICT Australia, Eveleigh, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Engineering, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gual</LastName><ForeName>Antoni</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Addictions Unit, Psychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraus</LastName><ForeName>Ludwig</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IFT Institut für Therapieforschung, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Social Research on Alcohol and Drugs (SoRAD), Stockholm University, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kreutz</LastName><ForeName>Reinhold</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liira</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>General Practice, School of Primary, Aboriginal and Rural Health Care, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Helsinki, Department of General Practice, and Helsinki University Central Hospital, Unit of Primary Health Care, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manthey</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-1231-3760</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany. jakob.manthey@tu-dresden.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Møller</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Noncommunicable Diseases through the Life Course, WHO Regional Office for Europe, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okruhlica</LastName><ForeName>Ľubomír</ForeName><Initials>Ľ</Initials><AffiliationInfo><Affiliation>Centrum pre Liecbu Drogovych Zavislosti, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roerecke</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Addiction Policy, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scafato</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>National Observatory on Alcohol, National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Società Italiana di Alcologia (SIA), Italian Society of Alcohology, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulte</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for Interdisciplinary Addiction Research, Hamburg University, Universitätsklinik Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segura-Garcia</LastName><ForeName>Lidia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Program on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shield</LastName><ForeName>Kevin David</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sierra</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hypertension and Vascular Risk Unit, Internal Medicine Department, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vyshinskiy</LastName><ForeName>Konstantin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Research Institute on Addictions, Federal Medical Research Centre for Psychiatry and Narcology n.a. V. Serbsky, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wojnar</LastName><ForeName>Marcin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarco</LastName><ForeName>José</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Drugs Intervention Group, semFYC, Ibiza Primary Health Care Center, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Eur Neuropsychopharmacol. 2013 Nov;23(11):1432-42</RefSource><PMID Version="1">23562264</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2003 May 14;289(18):2363-9</RefSource><PMID Version="1">12746359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Public Health (Oxf). 2011 Sep;33(3):412-21</RefSource><PMID Version="1">21169370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Alcohol Alcohol. 2014 Jan-Feb;49(1):66-78</RefSource><PMID Version="1">24232177</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Addiction. 2002 Mar;97(3):265-77</RefSource><PMID Version="1">11964100</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Alcohol Alcohol. 2008 Mar-Apr;43(2):192-7</RefSource><PMID Version="1">18039674</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dtsch Med Wochenschr. 2014 Nov;139(48):2457-62</RefSource><PMID Version="1">25409405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2014 Aug 2;384(9941):427-37</RefSource><PMID Version="1">24797573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2016 Dec 10;388(10062):e19-e23</RefSource><PMID Version="1">27371184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Alcohol Alcohol. 2013 Nov-Dec;48(6):633-40</RefSource><PMID Version="1">23926213</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hypertension. 2012 Oct;60(4):898-905</RefSource><PMID Version="1">22949530</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Addiction. 2017 Jun;112(6):968-1001</RefSource><PMID Version="1">28220587</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Addiction. 2009 Dec;104(12):1981-90</RefSource><PMID Version="1">19804464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Nephrol. 2013 Jan;9(1):51-8</RefSource><PMID Version="1">23165303</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Alcohol Alcohol. 2016 Jul;51(4):422-7</RefSource><PMID Version="1">26574600</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Addiction. 2008 Oct;103(10):1622-8</RefSource><PMID Version="1">18821872</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Addiction. 2010 May;105(5):817-43</RefSource><PMID Version="1">20331573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Clin (Barc). 2016 Jan 15;146(2):81-5</RefSource><PMID Version="1">26520609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hypertension. 2015 Feb;65(2):401-6</RefSource><PMID Version="1">25403604</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Pharmacol Physiol. 2006 Sep;33(9):847-52</RefSource><PMID Version="1">16922819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mayo Clin Proc. 2014 Mar;89(3):382-93</RefSource><PMID Version="1">24582196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can Fam Physician. 2015 Jun;61(6):515-21</RefSource><PMID Version="1">26071155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 1988 Sep 10;297(6649):663-8</RefSource><PMID Version="1">3052668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hypertension. 1999 Feb;33(2):653-7</RefSource><PMID Version="1">10024322</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hypertension. 2001 Nov;38(5):1112-7</RefSource><PMID Version="1">11711507</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Fam Pract. 2015 Jul 29;16:90</RefSource><PMID Version="1">26219430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Stud Alcohol. 2004 Nov;65(6):782-93</RefSource><PMID Version="1">15700517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Glob Health. 2015 Dec;3(12):e746-57</RefSource><PMID Version="1">26497599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Hypertens (Greenwich). 2005 Jun;7(6):346-51</RefSource><PMID Version="1">16088298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):795-801</RefSource><PMID Version="1">23703500</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hypertension. 2008 Apr;51(4):1080-7</RefSource><PMID Version="1">18259032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2013 Apr 15;73(8):706-13</RefSource><PMID Version="1">23237314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Addict Res. 2010;16(4):193-201</RefSource><PMID Version="1">20606444</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Psychiatry. 2015 Nov;30(8):885-93</RefSource><PMID Version="1">26647862</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2010 Dec 08;(12):CD001867</RefSource><PMID Version="1">21154349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Front Psychiatry. 2014 Sep 01;5:114</RefSource><PMID Version="1">25225487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2007 Dec 4;147(11):783-6</RefSource><PMID Version="1">18056662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2015 Feb 19;350:h715</RefSource><PMID Version="1">25698774</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2007 Apr 18;(2):CD004148</RefSource><PMID Version="1">17443541</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2011 Feb 07;342:d442</RefSource><PMID Version="1">21300712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2960-84</RefSource><PMID Version="1">24239922</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Prev Med. 2003 Aug;25(2):151-8</RefSource><PMID Version="1">12880884</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2015;2015:137020</RefSource><PMID Version="1">25629034</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can J Psychiatry. 2012 Jun;57(6):350-8</RefSource><PMID Version="1">22682572</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1981 Sep 26;2(8248):653-6</RefSource><PMID Version="1">6116043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Clin Belg. 2015 Dec;70(6):389-95</RefSource><PMID Version="1">26135944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gastroenterol Hepatol. 2008 Mar;23 Suppl 1:S2-8</RefSource><PMID Version="1">18336658</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2008 Jun 24;117(25):e510-26</RefSource><PMID Version="1">18574054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Fam Pract. 2016 Sep 08;17(1):130</RefSource><PMID Version="1">27608770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br Med J (Clin Res Ed). 1987 Apr 25;294(6579):1045-6</RefSource><PMID Version="1">3107685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Stud Alcohol. 2006 May;67(3):421-8</RefSource><PMID Version="1">16608152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Public Health. 2017 Apr 1;27(2):345-351</RefSource><PMID Version="1">27558943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hypertens. 1993 Sep;11(9):899-903</RefSource><PMID Version="1">8254172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Hypertens (Greenwich). 2012 Nov;14(11):792-8</RefSource><PMID Version="1">23126352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 1994;72(3):429-45</RefSource><PMID Version="1">8062401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Alcohol Alcohol. 2014 Jan-Feb;49(1):118-22</RefSource><PMID Version="1">24226811</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hypertens. 2013 Jul;31(7):1281-357</RefSource><PMID Version="1">23817082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hypertens. 2014 Jan;32(1):3-15</RefSource><PMID Version="1">24270181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 1993 Jan 25;153(2):154-83</RefSource><PMID Version="1">8422206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Alcohol Depend. 2012 Jun 1;123(1-3):7-14</RefSource><PMID Version="1">22197480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ Open. 2013 Aug 30;3(8):e003423</RefSource><PMID Version="1">23996822</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hypertens. 2013 Mar;31(3):630-1</RefSource><PMID Version="1">23615217</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Subst Abuse Treat Prev Policy. 2016 Oct 28;11(1):37</RefSource><PMID Version="1">27793173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2014 Feb 5;311(5):507-20</RefSource><PMID Version="1">24352797</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2005 Apr;34(2):413-21</RefSource><PMID Version="1">15659467</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Control Trials Cardiovasc Med. 2005 Apr 06;6(1):5</RefSource><PMID Version="1">15813971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Alcohol Alcohol. 2014 Sep-Oct;49(5):531-9</RefSource><PMID Version="1">25031247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Cancer. 2007 Sep 1;121(5):1132-7</RefSource><PMID Version="1">17487833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2011 Jun 24;342:d3621</RefSource><PMID Version="1">21705406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Addiction. 2016 Nov;111(11):1935-1945</RefSource><PMID Version="1">27237081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CMAJ. 1999 May 4;160(9 Suppl):S13-20</RefSource><PMID Version="1">10333849</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hypertens. 2012 Dec;30(12):2425-31</RefSource><PMID Version="1">22990354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Psychopharmacol. 2014 Aug;28(8):733-44</RefSource><PMID Version="1">24671340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Presse Med. 2014 Dec;43(12 Pt 1):1325-31</RefSource><PMID Version="1">25459067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Cardiol. 2006 Oct 15;98(8):1063-8</RefSource><PMID Version="1">17027572</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Fam Med. 2015 Jan-Feb;13(1):28-32</RefSource><PMID Version="1">25583889</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alcohol use</Keyword><Keyword MajorTopicYN="N">Blood pressure</Keyword><Keyword MajorTopicYN="N">Europe</Keyword><Keyword MajorTopicYN="N">Hypertension</Keyword><Keyword MajorTopicYN="N">Management</Keyword><Keyword MajorTopicYN="N">Primary healthcare</Keyword><Keyword MajorTopicYN="N">Recommendations</Keyword><Keyword MajorTopicYN="N">Screening</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>08</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28954635</ArticleId><ArticleId IdType="doi">10.1186/s12916-017-0934-1</ArticleId><ArticleId IdType="pii">10.1186/s12916-017-0934-1</ArticleId><ArticleId IdType="pmc">PMC5618725</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000467 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000467 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28954635
|texte= Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28954635" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |